Laparoscopic oophorectomy combined with breast surgery for breast cancer patients

Annals of Cancer Research and Therapy

Volumn 14, Issue 1, 2006, Pages 19-22

  Carmon, Moshe ^a   Olsha, Oded ^a   Levy Lahad, Ephrat ^b   Zuckerman, Boris ^b   Rivkin, Louis ^a   Beller, Uziel ^b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Breast cancer, operations; Gene, BRCA1; Gene, BRCA2; Oophorectomy, laparoscopic; Surgical procedures, operative, prophylaxis

Indexed keywords

EID: 76149144814     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt.14.19     Document Type: Article

References (19)

1. Rebbeck, T.R., Lynch, H.T., Neuhausen, S.L., et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346: 1616-1622.
2. Bergfeldt, K., Rydh, B., Granath, F., et al. (2002) Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 360: 891-894.
3. Blanchard, D.K. and Hartmann, L.C. (2000) Prophylactic surgery for women at high risk for breast cancer. Clin. Breast Cancer 1: 127-135.
4. Frank, T.S., Deffenbaugh, A.M., Reid, J.E., Hulick, M., Ward, B.E., Lingenfelter, B., Gumpper, K.L., Scholl, T., Tavtigian, S.V., Pruss, D.R. and Critchfield, G.C. (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J. Clin. Oncol. 15; 20 (6): 1480-1490.
5. Levine, D.A. and Gemignani, M.L. (2003) Prophylactic surgery in hereditary breast/ovarian cancer syndrome. Oncology (Huntingt) 17: 932-941.
6. Lerman, C., Hughes, C., Croyle, R.T., et al. (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med. 31: 75-80.
7. Di Prospero, L.S., Seminsky, M., Honeyford, J., et al. (2001) Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. CMAJ 164: 1005-1009.
8. Meijers-Heijboer, H., Brekelmans, C.T., Menke-Pluymers, M., et al. (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J. Clin. Oncol. 21: 1675-1681.
9. Meijers-Heijboer, H., van Geel, B., van Putten, W.L., et al. (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 345: 159-164.
10. Schairer, C., Persson, I., Falkeborn, M., et al. (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int. J. Cancer 70: 150-154.
11. Meijer, W.J., van Lindert, A.C. (1992) Prophylactic oophorectomy. Eur. J. Obstet. Gynecol. Reprod. Biol. 47: 59-65.
12. Galper, S., Gelman, R., Recht, A., et al. (2002) Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 52: 406-414.
13. Chlebowski, R.T. (2000) Reducing the risk of breast cancer. N. Engl. J. Med. 343: 191-198.
14. Tiller, K., Meiser, B., Butow, P., et al. (2002) Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol. Oncol. 86: 212-219.
15. Bateman, B.G., Kolp, L.A. and Hoeger, K. (1996) Complications of laparoscopy - operative and diagnostic. Fertil Steril 66: 30-35.
16. Mirhashemi, R., Harlow, B.L., Ginsburg, E.S., et al. (1998) Predicting risk of complications with gynecologic laparoscopic surgery. Obstet. Gynecol. 92: 327-331.
17. Recht, A., Come, S.E., Henderson, I.C., et al. (1996) The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med. 334: 1356-1361.
18. Esteva, F.J. and Hortobagyi, G.N. (1999) Adjuvant systemic therapy for primary breast cancer. Surg. Clin. North Am. 79: 1075-1090.
19. Cody, H.S. 3rd (2002) Current surgical management of breast cancer. Curr. Opin. Obstet. Gynecol. 14: 45-52.